Rebecca A. Hubbard

Rebecca A. Hubbard

Auto-generated profile, based on publicly available information

Rebecca A. Hubbard

Department of Biostatistics, School of Public Health, Brown University, Providence, RI

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2013 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
PCPaul Crane
Paul Crane
RWRod Walker
Rod Walker
RHRebecca A. Hubbard
Rebecca A. Hubbard
GLGe Li
Ge Li
DNDavid M. Nathan
David M. Nathan
ELEric B. Larson
Eric B. Larson
Diabetes is a risk factor for dementia. It is unknown whether higher glucose levels increase the risk of dementia in people without diabetes. We used 35,264 clinical measurements of glucose levels and 10,208 measurements of glycated hemoglobin levels from 2067 participants without dementia to examine the relationship between glucose levels and the risk of dementia. Participants were from the Adult Changes in Thought study and included 839 men and 1228 women whose mean age at baseline was 76 years; 232 participants had diabetes, and 1835 did not. We fit Cox regression models, stratified according to diabetes status and adjusted for age, sex, study cohort, educational level, level of exercise, blood pressure, and status with respect to coronary and cerebrovascular diseases, atrial fibrillation, smoking, and treatment for hypertension. During a median follow-up of 6.8 years, dementia developed in 524 participants (74 with diabetes and 450 without). Among participants without diabetes, higher average glucose levels within the preceding 5 years were related to an increased risk of dementia (P=0.01); with a glucose level of 115 mg per deciliter (6.4 mmol per liter) as compared with 100 mg per deciliter (5.5 mmol per liter), the adjusted hazard ratio for dementia was 1.18 (95% confidence interval [CI], 1.04 to 1.33). Among participants with diabetes, higher average glucose levels were also related to an increased risk of dementia (P=0.002); with a glucose level of 190 mg per deciliter (10.5 mmol per liter) as compared with 160 mg per deciliter (8.9 mmol per liter), the adjusted hazard ratio was 1.40 (95% CI, 1.12 to 1.76). Our results suggest that higher glucose levels may be a risk factor for dementia, even among persons without diabetes. (Funded by the National Institutes of Health.)

18 October 2011 in Annals of Internal Medicine
Verified
Journal Article
Closed access
RHRebecca A. Hubbard
Rebecca A. Hubbard
KKKarla Kerlikowske
Karla Kerlikowske
CFChris I. Flowers
Chris I. Flowers
BYBonnie C. Yankaskas
Bonnie C. Yankaskas
WZWeiwei Zhu
Weiwei Zhu
DMDiana L. Miglioretti
Diana L. Miglioretti
Debate continues regarding the optimal frequency for screening mammography. In this analysis of national data on screening mammography, investigators estimated the cumulative probability of false-p... Background: False-positive mammography results are common. Biennial screening may decrease the cumulative probability of false-positive results across many years of repeated screening but could als...

18 October 2011 in Annals of Internal Medicine
Verified
Journal Article
Closed access
KKKarla Kerlikowske
Karla Kerlikowske
RHRebecca A. Hubbard
Rebecca A. Hubbard
DMDiana L. Miglioretti
Diana L. Miglioretti
BGBerta M. Geller
Berta M. Geller
BYBonnie C. Yankaskas
Bonnie C. Yankaskas
FCfor the Breast Cancer Surveillance Consortium
for the Breast Cancer Surveillance Consortium
Few studies have examined the comparative effectiveness of digital versus film-screen mammography in U.S. community practice. In a large sample of women screened in community settings, digital and ... Background: Few studies have examined the comparative effectiveness of digital versus film-screen mammography in U.S. community practice. Objective: To determine whether the interpretive performanc...

13 May 2013 in JAMA Internal Medicine
Verified
Journal Article
Open access
PDF file
KKKarla Kerlikowske
Karla Kerlikowske
WZWeiwei Zhu
Weiwei Zhu
RHRebecca A. Hubbard
Rebecca A. Hubbard
BGBerta Geller
Berta Geller
KDKim Dittus
Kim Dittus
FCfor the Breast Cancer Surveillance Consortium
for the Breast Cancer Surveillance Consortium
In 2009, the US Preventive Services Task Force issued guidelines that biennial mammography, rather than the previously recommended mammography every 1 to 2 years, be performed for women aged 50 to 74 years.1 Because of insufficient evidence, the updated guidelines did not consider the influence of breast cancer risk factors beyond age.2 Women with risk factors that increase the chance of advanced-stage breast cancer at diagnosis may benefit from frequent screening to increase the chance of identifying tumors at an early stage. For example, high breast density is associated with larger tumor size,3-6 positive lymph nodes,4,7,8 and advanced-stage disease.9 Postmenopausal estrogen plus progestogen use for 5 years or more increases the likelihood of development and diagnosis of breast cancer at an advanced stage,10,11 and risk of advanced-stage disease is increased further in women with dense breasts who use postmenopausal hormone therapy (HT).9

18 February 2013 in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
Verified
Journal Article
Open access
PDF file
SGShelly Lynn Gray
Shelly Lynn Gray
MAMelissa L. Anderson
Melissa L. Anderson
RHRebecca A. Hubbard
Rebecca A. Hubbard
ALAndrea LaCroix
Andrea LaCroix
PCPaul Crane
Paul Crane
ELEric B. Larson
Eric B. Larson
We sought to examine whether frailty is associated with dementia, Alzheimer’s disease (AD), and non-AD dementia risk. This is a prospective population-based cohort derived from an integrated health maintenance organization. The sample consisted of 2,619 participants aged 65 and older without dementia at baseline followed from 1994 to 2010. Frailty was defined as having at least 3 of the following criteria: weakness (grip strength), slowness (walking speed), weight loss, low physical activity, and self-reported exhaustion. Follow-up occurred every 2 years to identify incident dementia, possible or probable AD, and non-AD dementia using standard research criteria. Covariates came from self-report and study measures. We used adjusted Cox proportional hazards models to examine the association between frailty and each outcome. Over a mean follow-up of 6.5 years, 521 participants developed dementia (of which 448 developed AD). In the model adjusted for age, sex, education, and race, the hazard ratio for frailty was 1.78 (95% confidence interval [CI] 1.32–2.40). In the fully adjusted models, the hazard ratio for frailty was 1.20 for all-cause dementia (95% CI 0.85–1.69), 1.08 for AD (95% CI 0.74–1.57), and 2.57 for non-AD dementia (95% CI 1.08–6.11). For all-cause dementia, we found an interaction between baseline cognitive score and frailty (p = .02); hazard ratio for frailty was 1.78 for those with higher global cognition (95% CI 1.14–2.78) and 0.79 for those with lower global cognition (95% CI 0.50–1.26). Frailty was associated with dementia when adjusting only for demographic variables but not in the fully adjusted model. Frailty was associated with higher risk of developing non-AD dementia but not AD. Although frailty was not associated with all-cause dementia in the entire sample, an association did exist in participants with higher cognitive scores. Mechanisms underlying these associations remain to be elucidated.

28 November 2024 in New England Journal of Medicine
Verified
Journal Article
Closed access
RHRebecca A. Hubbard
Rebecca A. Hubbard
CGConstantine A. Gatsonis
Constantine A. Gatsonis
JHJoseph W. Hogan
Joseph W. Hogan
DHDavid J. Hunter
David J. Hunter
SNSharon-Lise T. Normand
Sharon-Lise T. Normand
ATAndrea B. Troxel
Andrea B. Troxel